Abstract
We have previously demonstrated in in-silico, pre-clinical animal models, and finally human clinical studies the ability of a novel closed-loop vasopressor titration system to manage norepinephrine infusion rates to keep mean arterial blood pressure in a very tight range, reduce hypotension time and severity, and reduce overtreatment. We hypothesized that the same controller could, with modification for pharmacologic differences, suitably titrate a lower-potency longer duration of action agent like phenylephrine. Using the same physiologic simulation model as was used previously for in-silico testing of our controller for norepinephrine, we first updated the model to include a new vasopressor agent modeled after phenylephrine. A series of simulation tests patterned after our previous norepinephrine study was then conducted, this time using phenylephrine for management, in order to both test the system with the new agent and allow for comparisons between the two. Hundreds of simulation trials were conducted across a range of patient and environmental variances. The controller performance was characterized based on time in target, time above and below target, coefficient of variation, and using Varvel’s criteria. The controller kept the simulated patients’ MAP in target for 94% of management time in the simple scenarios and more than 85% of time in the most challenging scenarios. Varvel criteria were all under 1% error for expected pharmacologic responses and were consistent with those established for norepinephrine in our previous studies. The controller was able to acceptably titrate phenylephrine in this simulated patient model consistent with performance previously seen for norepinephrine after adjusting for the anticipated differences between the two agents.
Similar content being viewed by others
Data availability
By request to corresponding author.
Code availability
Simulator available by request to corresponding author.
References
Rinehart J, Joosten A, Ma M, Calderon MD, Cannesson M. Closed-loop vasopressor control: in-silico study of robustness against pharmacodynamic variability. J Clin Monit Comput. 2019;33(5):795–802.
Joosten A, Delaporte A, Alexander B, Su F, Creteur J, Vincent JL, Cannesson M, Rinehart J. Automated titration of vasopressor infusion using a closed-loop controller. Anesthesiology. 2019;130(3):394–403.
Rinehart J, Ma M, Calderon MD, Cannesson M. Feasibility of automated titration of vasopressor infusions using a novel closed-loop controller. J Clin Monit Comput. 2018;32(1):5–11.
Rinehart J, Cannesson M, Weeraman S, Barvais L, Obbergh LV, Joosten A. Closed-loop control of vasopressor administration in patients undergoing cardiac revascularization surgery. J Cardiothorac Vasc Anesth. 2020;34(11):3081–5.
Joosten A, Coeckelenbergh S, Alexander B, Cannesson M, Rinehart J. Feasibility of computer-assisted vasopressor infusion using continuous non-invasive blood pressure monitoring in high-risk patients undergoing renal transplant surgery. Anaesth Crit Care Pain Med. 2020;39(5):623–4.
Joosten A, Alexander B, Duranteau J, Taccone FS, Creteur J, Vincent JL, Cannesson M, Rinehart J. Feasibility of closed-loop titration of norepinephrine infusion in patients undergoing moderate- and high-risk surgery. Br J Anaesth. 2019;123(4):430–8.
Joosten A, Rinehart J, Van der Linden P, Alexander B, Penna C, De Montblanc J, Cannesson M, Vincent JL, Vicaut E, Duranteau J. Computer-assisted individualized hemodynamic management reduces intraoperative hypotension in intermediate- and high-risk surgery: a randomized controlled trial. Anesthesiology. 2021;135:258–72.
Joosten A, Chirnoaga D, Van der Linden P, Barvais L, Alexander B, Duranteau J, Vincent JL, Cannesson M, Rinehart J. Automated closed-loop versus manually controlled norepinephrine infusion in patients undergoing intermediate- to high-risk abdominal surgery: a randomised controlled trial. Br J Anaesth. 2021;126(1):210–8.
Michard F, Liu N, Kurz A. The future of intraoperative blood pressure management. J Clin Monit Comput. 2018;32(1):1–4.
Hulting J, Thorstrand C. Hemodynamic effects of norepinephrine in severe hypnotic drug poisoning with arterial hypotension. Acta Med Scand. 1972;192(5):447–53.
Kroppenstedt SN, Thomale UW, Griebenow M, Sakowitz OW, Schaser KD, Mayr PS, Unterberg AW, Stover JF. Effects of early and late intravenous norepinephrine infusion on cerebral perfusion, microcirculation, brain-tissue oxygenation, and edema formation in brain-injured rats. Crit Care Med. 2003;31(8):2211–21.
Cavus E, Meybohm P, Dorges V, Stadlbauer KH, Wenzel V, Weiss H, Scholz J, Bein B. Regional and local brain oxygenation during hemorrhagic shock: a prospective experimental study on the effects of small-volume resuscitation with norepinephrine. J Trauma. 2008;64(3):641–8.
Xu T, Zheng J, An XH, Xu ZF, Wang F. Norepinephrine intravenous prophylactic bolus versus rescue bolus to prevent and treat maternal hypotension after combined spinal and epidural anesthesia during cesarean delivery: a sequential dose-finding study. Ann Transl Med. 2019;7(18):451.
Rokyta R Jr, Tesarova J, Pechman V, Gajdos P, Krouzecky A. The effects of short-term norepinephrine up-titration on hemodynamics in cardiogenic shock. Physiol Res. 2010;59(3):373–8.
Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fordos A, Sporn P. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med. 1993;19(3):151–4.
Christensen LK, Armstead VE, Bilyeu DP, Johnson KE, Friesen RH. Hemodynamic responses and plasma phenylephrine concentrations associated with intranasal phenylephrine in children. Paediatr Anaesth. 2017;27(7):768–73.
Brassard P, Pelletier C, Martin M, Gagne N, Poirier P, Ainslie PN, Caouette M, Bussieres JS. Influence of norepinephrine and phenylephrine on frontal lobe oxygenation during cardiopulmonary bypass in patients with diabetes. J Cardiothorac Vasc Anesth. 2014;28(3):608–17.
Wang X, Mao M, Zhang SS, Wang ZH, Xu SQ, Shen XF. Bolus norepinephrine and phenylephrine for maternal hypotension during elective cesarean section with spinal anesthesia: a randomized, double-blinded study. Chin Med J (Engl). 2020;133(5):509–16.
Wang X, Mao M, Liu S, Xu S, Yang J. A comparative study of bolus norepinephrine, phenylephrine, and ephedrine for the treatment of maternal hypotension in parturient with preeclampsia during caesarean delivery under spinal anesthesia. Med Sci Monit. 2019;25:1093–101.
Kwak YL, Lee CS, Park YH, Hong YW. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*. Anaesthesia. 2002;57(1):9–14.
Chou J, Rinehart JB. Computer simulated modeling of healthy and diseased right ventricular and pulmonary circulation. J Clin Monit Comput. 2018;32(6):1015–24.
Rinehart J, Alexander B, Le Manach Y, Hofer C, Tavernier B, Kain ZN, Cannesson M. Evaluation of a novel closed-loop fluid-administration system based on dynamic predictors of fluid responsiveness: an in silico simulation study. Crit Care. 2011;15(6):R278.
Acknowledgements
Not applicable.
Funding
No funding was provided except for departmental support of the authors.
Author information
Authors and Affiliations
Contributions
MM—Performed simulations, analysis, and drafting of the manuscript. AH—Sourced drug references, performed simulations, drafting of manuscript. AJ, JR—Study design, analysis, drafting of manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Michael Ma, Angela Ho—None. Alexandre Joosten, Joseph Rinehart—Consultant for Edwards Lifesciences, equity interest in Perceptive Medical Inc.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ma, M., Ho, A., Joosten, A. et al. In-silico analysis of closed-loop vasopressor control of phenylephrine versus norepinephrine. J Clin Monit Comput 36, 1305–1313 (2022). https://doi.org/10.1007/s10877-021-00761-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10877-021-00761-6